CEL-SCI logo

CVM - CEL-SCI News Story

$12.49 0.3  2.3%

Last Trade - 9:10pm

Sector
Healthcare
Size
Mid Cap
Market Cap £356.1m
Enterprise Value £350.7m
Revenue £457k
Position in Universe 3091st / 6432

BRIEF-CEL-SCI Says Awarded European Patent For LEAPS Vaccine In Treatment Of Rheumatoid Arthritis

Fri 18th September, 2020 2:48pm
Sept 18 (Reuters) - CEL-SCI Corp  CVM.A :
    * CEL-SCI AWARDED EUROPEAN PATENT FOR LEAPS VACCINE IN
TREATMENT
OF RHEUMATOID ARTHRITIS

Source text for Eikon:  ID:nBw3sdN7Ka 
Further company coverage:  CVM.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.